These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3201313)
1. [Treatment of breast cancer with regional lymph node involvement]. Riabov IuV; Reziapkin VV; Rudi ZA Sov Med; 1988; (8):105-8. PubMed ID: 3201313 [No Abstract] [Full Text] [Related]
2. 5-year follow-up after sentinel node mapping for breast cancer demonstrates better than expected treatment outcomes. Fuhrman GM; Gambino J; Bolton JS; Farr G; Jiang X Am Surg; 2005 Jul; 71(7):564-9; discussion 569-70. PubMed ID: 16089119 [TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients]. Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207 [TBL] [Abstract][Full Text] [Related]
4. [Conservative treatment of cancer of the breast in Tunisia]. Mesedi W; Benna F; Gamoudi A; Bouaouina N; Sellami D; Rahal K; Ben Youssef R; Ben Romdhane K; Ben Abdallah M; Maalej M Tunis Med; 1993 Mar; 71(3):129-34. PubMed ID: 8351725 [No Abstract] [Full Text] [Related]
5. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP Breast J; 2005; 11(5):338-43. PubMed ID: 16174155 [TBL] [Abstract][Full Text] [Related]
6. [Late results of combination treatment of breast cancer]. Kyshtobaev OI Vopr Onkol; 1981; 27(4):87-90. PubMed ID: 7233881 [TBL] [Abstract][Full Text] [Related]
7. [Inflammatory breast cancer: clinical course, diagnosis and treatment]. Borisov VI; Chkhikvadze TV Vopr Onkol; 2008; 54(1):86-9. PubMed ID: 18416065 [TBL] [Abstract][Full Text] [Related]
8. [Indications for adjuvant radiotherapy in primary breast-saving and ablative treatment of breast cancer]. Bahnsen J Gynakologe; 1994 Apr; 27(2):64-9. PubMed ID: 8039744 [No Abstract] [Full Text] [Related]
9. [Apropos of 45 recurrences after conservative treatment for breast cancer]. Abbes M; Lagrange JL; Frenay M; Ettore F Ann Chir; 1987; 41(5):327-31. PubMed ID: 3662373 [No Abstract] [Full Text] [Related]
10. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Harris EE; Hwang WT; Seyednejad F; Solin LJ Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of breast cancer with ipsilateral supraclavicular node metastases]. Ning L; Yu J; Lin C Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):139-41. PubMed ID: 7656807 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the effect of ovariectomy in patients with stage III breast cancer]. Semiglazov VF; Moiseenko VM; Filatov VN; Tsyrlina EV; Seleznev IK Vestn Khir Im I I Grek; 1987 Jan; 138(1):47-50. PubMed ID: 3590535 [TBL] [Abstract][Full Text] [Related]
13. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer. Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886 [TBL] [Abstract][Full Text] [Related]
14. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups]. Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408 [TBL] [Abstract][Full Text] [Related]
15. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
16. [Radiotherapy following a breast-preserving operation in breast carcinoma]. Kolotas C; Zamboglou N; Audretsch W; Rezai M; Muskalla K; Schnabel T; Bojar H; Schmitt G Strahlenther Onkol; 1993 Feb; 169(2):96-101. PubMed ID: 8451730 [TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535 [TBL] [Abstract][Full Text] [Related]
18. [Principles of adjuvant drug therapy in breast cancer]. Castiglione M; Schnürch HG; Bender HG; Goldhirsch A Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743 [No Abstract] [Full Text] [Related]
19. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
20. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy. Atahan IL; Ozyigit G; Yildiz F; Gurkaynak M; Selek U; Sari S; Hayran M Breast J; 2008; 14(3):245-9. PubMed ID: 18433402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]